Assembly Biosciences, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Assembly Biosciences, Inc. (ASMB) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.50% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-19
- Assembly Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.50%.
- Assembly Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.50%.
- Assembly Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.20%.
- Assembly Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -0.60%, a 700.00% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -0.50% 10-K · filed 2026-03-19 | |
| 2023-12-31 | -0.50% 10-K · filed 2025-03-20 | |
| 2022-12-31 | -0.20% 10-K · filed 2024-03-28 | |
| 2021-12-31 | -0.60% 10-K · filed 2023-03-22 | |
| 2020-12-31 | 0.10% 10-K · filed 2022-03-11 | |
| 2019-12-31 | -0.20% 10-K · filed 2021-02-25 | |
| 2018-12-31 | 0.80% 10-K · filed 2021-02-25 | -0.40% 10-K · filed 2019-02-28 |
| 2017-12-31 | -0.30% 10-K · filed 2020-03-04 | 0.30% 10-K · filed 2018-03-08 |
| 2016-12-31 | 2.30% 10-K · filed 2019-02-28 | |
| 2015-12-31 | 0.10% 10-K · filed 2018-03-08 | |
| 2014-12-31 | 0.00% 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |